GleamWall
中文EN

VCEL Vericel Corp

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 887359 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY25.3%
TTM net income YoY154.6%
TTM EPS YoY146.2%
Revenue 3-yr CAGR20.5%
Net income 3-yr CAGR—

Margins

Gross margin74.5%
Operating margin8.3%
Net margin10.3%
FCF margin17.9%
EBITDA margin12.4%

Returns

ROE9.4%
ROA6.9%
ROIC (approx.)9.0%
Asset turnover0.67x

Leverage & solvency

Liabilities / assets25.7%
Debt / equity0.00x
Current ratio5.13x
Interest coverage42.01x

Cash quality & payout

Operating cash flow / net income1.96x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue2.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$276.26M$237.22M
Cost of revenue$70.66M$65.12M
Gross profit$205.60M$172.11M
R&D expense$27.56M$24.80M
SG&A expense$166.99M$142.79M
Operating income$11.04M$4.52M
Interest expense$630,000$614,000
Pretax income$17.38M$10.51M
Income tax$859,000$148,000
Net income$16.52M$10.36M
EBITDA$22.59M$10.02M
EPS (basic)0.330.21
EPS (diluted)0.320.20
Weighted avg. shares (diluted)52.15M51.68M
Balance sheet
Cash & equivalents$100.09M$85.05M
Short-term investments$37.41M$41.69M
Receivables$84.63M$61.38M
Inventory$17.56M$17.37M
Current assets$247.44M$212.78M
PP&E, net$108.40M$103.16M
Intangibles$5.62M$6.25M
Total assets$487.97M$432.72M
Current liabilities$49.15M$50.29M
Total liabilities$133.33M$140.75M
Shareholders' equity$354.64M$291.97M
Shares outstanding50.62M49.63M
Cash flow statement
Operating cash flow$51.91M$58.16M
Capital expenditure$27.16M$63.97M
Free cash flow$24.75M-$5.81M
Investing cash flow-$43.94M-$79.03M
Financing cash flow$7.07M$19.05M
Depreciation & amortization$11.54M$5.50M
Stock-based compensation$38.77M$36.49M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.